Utibe R Essien Selected Research

Utibe R Essien Research Topics

12	Atrial Fibrillation 05/2024 - 12/2018
4	Heart Failure 12/2023 - 01/2022
3	Type 2 Diabetes Mellitus (MODY) 09/2022 - 12/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 12/2021
2	COVID-19 01/2023 - 01/2023
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2019
2	Stroke (Strokes) 02/2020 - 01/2020
1	Dyslipidemias (Dyslipidemia) 12/2023
1	Fibrosis (Cirrhosis) 01/2022
1	Hepatic Encephalopathy 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Soft Tissue Infections 12/2021
1	Weight Loss (Weight Reduction) 12/2021
1	Hemorrhage 02/2020
1	Opioid-Related Disorders (Opiate Addiction) 01/2020
1	Opiate Overdose 01/2020
1	Thrombosis (Thrombus) 01/2020
1	Myocardial Infarction 01/2020
1	Neoplasms (Cancer) 01/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019

9	AnticoagulantsIBA 05/2024 - 12/2018
3	Factor Xa InhibitorsIBA 01/2022 - 12/2018
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 09/2022 - 12/2021
2	Hypoglycemic Agents (Hypoglycemics)IBA 09/2022 - 01/2022
2	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 02/2020
1	Cardiovascular AgentsIBA 12/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	tixagevimabIBA 01/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	cilgavimabIBA 01/2023
1	SodiumIBA 01/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 09/2022
1	Lactulose (Duphalac)FDA LinkGeneric 01/2022
1	Angiotensin Receptor AntagonistsIBA 01/2022
1	Rifaximin (L 105)FDA Link 01/2022
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2021
1	Opioid Analgesics (Opioids)IBA 01/2020
1	Particulate MatterIBA 01/2020
1	oxidized low density lipoproteinIBA 01/2019